Cadence Pharmaceuticals: Cadence Pharmaceuticals (CADX) Announces Quarterly Earnings, Misses Expectations By $0.01 EPS

Cadence Pharmaceuticals (NASDAQ:CADX) issued its quarterly earnings data on Friday. The company reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by $0.01, Stock Ratings Network.com reports. The company had revenue of $33.30 million for the quarter, compared to the consensus estimate of $32.51 million. Shares of Cadence Pharmaceuticals […]Cadence Pharmaceuticals (CADX) Announces Quarterly Earnings, Misses Expectations By $0.01 EPS is a post from: ZolmaxThe post Cadence Pharmaceuticals (CADX) Announces Quarterly Earnings, Misses Expectations By $0.01 EPS appeared first on Zolmax.